Tested Applications
| Positive WB detected in | HepG2 cells, MCF-7 cells, A431 cells, HeLa cells |
| Positive IHC detected in | human breast cancer tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
| Positive FC (Intra) detected in | HeLa cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:3000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| Flow Cytometry (FC) (INTRA) | FC (INTRA) : 0.20 ug per 10^6 cells in a 100 µl suspension |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
20234-1-AP targets CSNK2B in WB, IHC, IF, FC (Intra), ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human, mouse |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
Peptide Predict reactive species |
| Full Name | casein kinase 2, beta polypeptide |
| Calculated Molecular Weight | 25 kDa |
| Observed Molecular Weight | 25 kDa |
| GenBank Accession Number | NM_001320 |
| Gene Symbol | CSNK2B |
| Gene ID (NCBI) | 1460 |
| RRID | AB_10733246 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P67870 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
CSNK2B, also named as CK2N, G5A nd CK II beta, belongs to the casein kinase 2 subunit beta family. CSNK2B participates in Wnt signaling. It plays a complex role in regulating the basal catalytic activity of the alpha subunit. The antibody is specific to CSNK2B.
Protocols
| Product Specific Protocols | |
|---|---|
| FC protocol for CSNK2B antibody 20234-1-AP | Download protocol |
| IHC protocol for CSNK2B antibody 20234-1-AP | Download protocol |
| WB protocol for CSNK2B antibody 20234-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The CSNK2B Polyclonal antibody (Cat# 20234-1-AP) has 12 citations published in journals including Nature Communications, Redox Biology, Molecular Cell, Journal of Experimental & Clinical Cancer Research, Advanced Science, Phytomedicine, Cell Genomics, Frontiers in Molecular Neuroscience, Journal of Cell Communication and Signaling, Experimental Cell Research, Human Cell, and Technology in Cancer Research & Treatment. Research fields span oncology (HNSCC, gastric, lung, liver, colorectal, and cervical cancers), redox biology, epigenetics, neurodegeneration, and cell signaling pathways.
| Species | Application | Title |
|---|---|---|
Nat Commun Phosphorylation of PA28γ by CK2 kinase facilitates HNSCC tumor formation and progression. | ||
Redox Biol Redox-sensitive activation of CCL7 by BRG1 in hepatocytes during liver injury. | ||
Mol Cell Functional Landscape of PCGF Proteins Reveals Both RING1A/B-Dependent-and RING1A/B-Independent-Specific Activities. | ||
J Exp Clin Cancer Res Overexpression of NELFE contributes to gastric cancer progression via Wnt/β-catenin signaling-mediated activation of CSNK2B expression.
| ||
Adv Sci (Weinh) CK2B Induces CD8+ T-Cell Exhaustion through HDAC8-Mediated Epigenetic Reprogramming to Limit the Efficacy of Anti-PD-1 Therapy in Non-Small-Cell Lung Cancer | ||
Phytomedicine Spiropachysine A suppresses hepatocellular carcinoma proliferation by inducing methuosis in vitro and in vivo. |
